Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Arsenic Trioxide × Tumor-Agnostic × Clear all

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 11 Lymphoid 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1 CNS 1

Conditions

Interventions

Radiotherapy 9 Cisplatin 9 Gemcitabine 7 Drug Therapy 7 Blood Specimen Collection 7 Fluorouracil 6 Docetaxel 6 Carboplatin 6 Capecitabine 6 Pemetrexed 5 Nivolumab 5 Trastuzumab 4 Positron Emission Tomography Computed Tomography 4 Paclitaxel 4 Oxaliplatin 4 Everolimus 4 Cetuximab 4 Biopsy 4 pembrolizumab 3 indibulin 3 icotinib 3 Surveys and Questionnaires 3 Standard of Care 3 Radiosurgery 3 Neoadjuvant Therapy 3 Magnetic Resonance Spectroscopy 3 Interleukin-2 3 Immune Checkpoint Inhibitors 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Gallium-68 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04695223 2021-01-06

Arsenic Trioxide for Structural p53 Mutations

Shanghai Changzheng Hospital

Phase 2 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡